{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:38:36Z","timestamp":1780364316134,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Annals of Otorhinolaryngology, Head and Neck Diseases"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.anorl.2018.08.017","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T19:09:39Z","timestamp":1552417779000},"page":"317-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transient vocal fold lesion and hoarseness associated with the use of ramucirumab: Case report"],"prefix":"10.1016","volume":"136","author":[{"given":"\u00c9.G.A.","family":"Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.L.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anorl.2018.08.017_bib0075","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","article-title":"Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data","volume":"24","author":"Wagner","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anorl.2018.08.017_bib0080","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2011.39.4585","article-title":"Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone","volume":"30","author":"Kang","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anorl.2018.08.017_bib0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGF-A and tumour angiogenesis","volume":"273","author":"Claesson-Welsh","year":"2013","journal-title":"J Intern Med"},{"issue":"9911","key":"10.1016\/j.anorl.2018.08.017_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastroesophageal junction adenocarcinoma (REGARD): an international, randomized, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Funchs","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.anorl.2018.08.017_bib0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","article-title":"Adverse effects of anticancer agents that target the VEGF pathway","volume":"6","author":"Chen","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anorl.2018.08.017_bib0100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ctrv.2010.01.003","article-title":"Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma","volume":"36","author":"Schmidinger","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.anorl.2018.08.017_bib0105","series-title":"Cancer staging manual, 3rd printing","author":"American Joint Committee on Cancer (AJCC)","year":"2018"},{"key":"10.1016\/j.anorl.2018.08.017_bib0110","unstructured":"https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5\u00d711.pdf [Accessed on March 09, 2018]."},{"key":"10.1016\/j.anorl.2018.08.017_bib0115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s10637-013-0049-2","article-title":"Dysphonia induced by anti-angiogenic compounds","volume":"32","author":"Saavedra","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.anorl.2018.08.017_bib0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaoto.2014.1766","article-title":"Hoarseness after metastatic colon cancer treatment","volume":"140","author":"Caruso","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"Sppl. 4","key":"10.1016\/j.anorl.2018.08.017_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/annonc\/mdh930","article-title":"Molecular targeting: targeting angiogenesis in solid tumors","volume":"15","author":"Soria","year":"2004","journal-title":"Ann Onco"},{"issue":"11","key":"10.1016\/j.anorl.2018.08.017_bib0130","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomized phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anorl.2018.08.017_bib0135","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s10637-009-9314-9","article-title":"Dysphonia induced by vascular endothelium growth factor\/vascular endothelium growth factor receptor inhibitors","volume":"28","author":"Hartl","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.anorl.2018.08.017_bib0140","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"}],"container-title":["European Annals of Otorhinolaryngology, Head and Neck Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879729619300304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879729619300304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:12:25Z","timestamp":1761819145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879729619300304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1879729619300304"],"URL":"https:\/\/doi.org\/10.1016\/j.anorl.2018.08.017","relation":{},"ISSN":["1879-7296"],"issn-type":[{"value":"1879-7296","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient vocal fold lesion and hoarseness associated with the use of ramucirumab: Case report","name":"articletitle","label":"Article Title"},{"value":"European Annals of Otorhinolaryngology, Head and Neck Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anorl.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}